Create a free PetfoodIndustry account to continue reading

Mars taps Andres-Luna to lead Science & Diagnostics

Carlos Andres-Luna, a Royal Canin executive, will oversee Mars Petcare’s veterinary diagnostics, genomics and science operations beginning Jan. 1.

Professional headshot of a smiling man in dark blazer and light blue shirt against gray background
Carlos Andres-Luna
Mars Inc.

Mars named Carlos Andres-Luna as global president of its Science & Diagnostics division, which includes veterinary diagnostics brands Antech and Vetsource, plus genomics services like Wisdom Panel. Andres-Luna, who joined Mars in 2009 and most recently led Royal Canin's rapid growth markets, will oversee the division's research agenda and report to Mars Petcare's global president starting January 1.

  • Carlos Andres-Luna appointed global president of Mars Science & Diagnostics, part of the $30 billion Mars Petcare business, effective January 1
  • Division portfolio includes Antech (veterinary diagnostics and imaging), Vetsource (pharmacy delivery and clinic software), and Wisdom Panel (DNA testing)
  • Andres-Luna will lead the company's science agenda in partnership with the Waltham Petcare Science Institute, which has conducted pet health research for over 60 years
  • Internal promotion: Andres-Luna joined Mars in 2009 and previously served as regional president for rapid growth markets at Royal Canin
  • He succeeds Katie Devine and brings experience in veterinary partnerships and customer leadership from his tenure at Royal Canin and prior roles at Bain & Company

Mars named Carlos Andres-Luna global president of Mars Science & Diagnostics, a division of the company’s more than $30 billion global Mars Petcare business. Andres-Luna will start in the role Jan. 1 and report to Marc Carena, global president of Mars Petcare.

In his new role, Andres-Luna will lead the global Science & Diagnostics division. The division’s portfolio includes veterinary diagnostics under the Antech brand, covering in-house diagnostics, reference laboratories, imaging equipment and services, and integrated software platforms. It also includes Vetsource, which provides home delivery for pharmacy and nutrition products along with software and data services for veterinary clinics, and a global genomics business offering DNA testing through Wisdom Panel and Antagene.

Andres-Luna will also lead the company’s science agenda, working with the Waltham Petcare Science Institute, which has conducted pet health research for more than 60 years.

Andres-Luna was promoted from within Mars. He most recently served as regional president for rapid growth markets at Royal Canin, where he worked with breeders and veterinarians.

“I’m excited to welcome Carlos to the team,” Carena said. “He has built a fantastic career across Mars, driving purpose-led growth. We are confident he will make a significant contribution to our Science & Diagnostics business, driving positive health outcomes for pets and delivering on our purpose: a better world for pets.”

“Pets make our lives infinitely better, and our talented team of researchers, scientists, veterinarians and engineers work to advance science and diagnostics to make sure every pet gets the care they deserve,” Andres-Luna said. “I’m delighted to join them, and to work together to deliver even greater impact.”

Andres-Luna joined Mars in 2009 and has held several leadership roles at Royal Canin, including chief customer officer and general manager of European key accounts, where he managed partnerships with major veterinary groups. Before joining Mars, he was a consultant at Bain & Company and worked at J.P. Morgan Investment Bank. He holds a degree in economics and business administration from San Pablo CEU University in Madrid and ESCE Paris, and earned an MBA from IESE Business School.

Andres-Luna succeeds Katie Devine, who has left Mars.

Page 1 of 768
Next Page